Infectious Disease Puscast #63

Infectious Disease Puscast

On episode #63 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 8/29/24 – 9/13/24.

Host: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Viral
• Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach (OFID)
• A New Orthonairovirus Associated with Human Febrile Illness (NEJM)
• Farmed fur animals harbour viruses with zoonotic spillover potential(Nature)
• A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With Mpox (OFID)
• A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy (Transplant Infectious Disease)
• A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication (JID)
• Bacterial
• FDA clears newLyme disease test (CIDRAP)
• Lyme ImmunoBlot Receives FDA Clearance(Accesswire)
• The Utilization Of Echocardiography In Children With Staphylococcus aureus Bacteremia (Journal of Pediatric Infectious Diseases Society)
• Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?(BMC Infectious Diseases)
• Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia (OFID)
• FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis
• FDA)
• Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia (CID)
• Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better? (BMC Infectious Diseases)
• Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia (OFID)
• Fungal
• The Last of US Season 2 (YouTube)
• Incidence and risk factors for invasive fungal infections in patients initiating TNF-alpha inhibitors for inflammatory bowel disease and rheumatoid arthritis (CID)
• Parasitic
• Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice(Science Translational Medicine)
• Miscellaneous
• Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin B (OFID)
• The Impact of Infectious Diseases Scholarly Mentorship on Subsequent Infectious Disease Fellowship Application (CID)

Music is by Ronald Jenkees

Information on this podcast should not be considered as medical advice.